Safety and Efficacy of Lidoderm (Lidocaine Patch 5%) in Treating Moderate to Severe Pain Associated With Carpal Tunnel Syndrome
Clinical trial NCT00266214 · TERMINATED
Trial details
- NCT number
- NCT00266214
- Sponsor
- Endo USA Inc., a Keenova Therapeutics Company
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2005-11-01
- Primary completion
- 2007-01-01
- Enrollment
- 210
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.